Suggestions

Du même auteur

A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST.

Archive ouverte | Blay, Jean-Yves | CCSD

International audience. The introduction of molecularly targeted therapies has ushered in a considerable transformation in the management of gastrointestinal stromal tumors (GIST) that currently defines the paradigm...

[A very disturbing evolution].

Archive ouverte | Blay, Jean-Yves | CCSD

International audience

Nilotinib: a novel, selective tyrosine kinase inhibitor.

Archive ouverte | Blay, Jean-Yves | CCSD

International audience. The development of tyrosine kinase inhibitors (TKIs) for the treatment of chronic myelogenous leukemia (CML) was based on the discovery that CML stem and progenitor cells overexpress the abno...

Chargement des enrichissements...